DANVERS, Mass., May 26, 2021 /PRNewswire/ -- The Scleroderma Foundation is pleased to announce the hiring of Mary J. Wheatley, IOM, CAE as CEO of the foundation, effective July 1, 2021. Wheatley succeeds Robert J. Riggs, who announced his departure last November after 25 years of leadership.
Riggs guided the organization through the merger of the United Scleroderma Foundation and the Scleroderma Federation, and recently led development of a strategic plan to enhance fundraising capabilities and to realign organizational management.
"This is an exciting time for the Scleroderma Foundation," said Cos Mallozzi, chair of the foundation's national board of directors. "We thank Robert for his years of dedication and look forward to the foundation's future under Mary's leadership."
Wheatley is a proven nonprofit executive with more than 15 years of experience in research administration and nonprofit management. She joins the Scleroderma Foundation having served as executive director of the Rheumatology Research Foundation (RRF) since 2014, where she provided expertise, leadership and management for all functions within the organization. Over the past 13 years, she was a driving force in helping RRF grow significantly, not only in size and scope, but also in national recognition. During her tenure, she oversaw two successful fundraising campaigns, raising more than $135 million for rheumatology research and training.
